Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A recent win by DeepMind, an AI lab owned by Google parent company Alphabet, in a protein-folding problem competition has scientists wondering how the technology can change the drug discovery industry, according to a report by The New York Times.
Walmart is allowing its employees to see a provider for only $4 but the visitation has to be through telemedicine, according to a report from the Associated Press.
An AI algorithm helped determine adult women’s brains are, on average, a few years younger than the brains of males of the same age, according to research published in the Proceedings of the National Academy of Sciences.
Reuters reports the Trump administration will take executive action in the next few weeks to ensure the U.S. keeps abreast of research and development opportunities in “industries of the future”—including AI and 5G networks.
Northwell Health, a New York-based healthcare network, is integrating predictive AI software into the electronic medical records (EMRs) at 15 of its hospitals to identify patients at risk of being readmitted to the hospital.
A deep learning model classified acute and nonacute pediatric elbow abnormalities on radiographs in trauma with 88 percent accuracy, according to new research published in Radiology: Artificial Intelligence.
Machine learning models could be used to help improve the prediction ability of emergency room (ER) triage methods, after a JAMA study showed the technology was better at making clinical predictions than traditional approaches.
Prior authorization that requires physicians to get approval from health insurers for certain drugs, tests and treatments isn’t good for patients, according to a survey of 1,000 practicing physicians from the American Medical Association (AMA).
The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns.
If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?
